Ann: Operational Update, page-11

I still think their biggest chance is going to be in the cpp and drug delivery or antibiotic Areas as with the recent deal Extension. i am no medical expert but it seems to me the most promising breakthroughs in cancer Treatment are being made in the Areas of immune System type therapies where the immune System is reprogrammed to 'see' and attack cancer cells. I think at the end of the journey this will be the cure. MYC and cpp seem to still have an unbelievebly Long journey to travel before coming Close to cash generating.

These updates seem to Keep indicating to me that we are concentrating on the cancer data packs but in the meantime much more promising other uses for our tech Keep popping up, and it seems These other uses are the ones creating interest? but i guess who knows what those signing the ND Agreements are targetting from our Portfolio.

Either way nice to see the Price stepping up and at the Moment the fear of a no from medimune has gone and taken a weight off.